Child & Adolescent Psychopharmacology 2012 | Massachusetts General Hospital Academy

Mar 9, 2012 - Mar 11, 2012

Child & Adolescent Psychopharmacology 2012

Joseph Biederman, MD
Thomas J. Spencer, MD
Timothy E. Wilens, MD

Live Event

Live Learning

Description

Register Early to Obtain the Lowest Rates! Early Bird Deadline is February 17, 2012. Click on the “Pricing” tab for more details!

The comprehensive three-day curriculum highlights the latest research findings and their practical clinical applications across the spectrum of child and adolescent psychiatric disorders - ADHD, autism, depression, eating disorders, OCD, psychosis, substance abuse, Tourette's, and much more.

This conference provides direct, personal access to globally-recognized faculty from the Massachusetts General Hospital Department of Psychiatry, Harvard Medical School, New York University, University of Texas, and more. It's the only conference where you can engage experts like Drs. Joseph Biederman, Thomas Spencer, and Timothy Wilens, and Janet Wozniak, ask your most pressing clinical questions, and leave with guidance and solutions to the challenges you face every day in clinical practice.

Learning Objectives

At the end of this educational activity, participants should be able to:

Recognize the presentation, diagnosis, and current treatment options available for attention deficit and hyeractivity in childhood and adolescence.
Identify the presentation, diagnosis, and current treatment options available for behavioral problems and pervasive developmental disorders.
Discuss the presentation diagnosis, and current treatment options available for drepression, psychosis, manic depression and anxiety.
Compare and contrast basic neuropharmacology, neuropsychologic testing data, psychopharmacologic properties of compounds, and the implications of psychiatric genetics for guiding day-to-day pediatric psychopharmacology treatment.
Recognize the risk management issues associated with adolescent substance abuse and smoking, ethical and safe use of psychotropics, suicide risk and prevention, cardiovascular side effects and medical liability of stimulants, and liability prevention in psychopharmacology.

Agenda

Agenda subject to change.

Friday, March 9, 2012

7:00 - 7:45AM	Continental Breakfast
7:00 - 7:45AM	Registration
7:45 - 8:00AM	Introduction Joseph Biederman, MD; Thomas J. Spencer, MD; Timothy E. Wilens, MD
8:00 - 9:00AM	Diagnosis & Assessment in Pediatric Psychopharmacology Joseph Biederman, MD
9:00 - 9:45AM	Developmental Psychopharmacology Pradeep Bhide, MD
9:45 - 10:30AM	Implications of Psychiatric Genetics for Psychopharmacology Roy H. Perlis, MD
10:30 - 10:45AM	Coffee Break
10:45 - 11:45AM	ADHD Across the Life Cycle Joseph Biederman, MD
11:45 - 1:00PM	Lunch (On your own)
1:00 - 2:00PM	Pharmacologic Treatment of ADHD Across the Life Cycle: Stimulants Thomas J. Spencer, MD
2:00 - 3:00PM	Pharmacologic Treatment of ADHD Across the Life Cycle: Non-Stimulants Timothy E. Wilens, MD
3:00 - 3:15PM	Coffee Break
3:15 - 4:15PM**	Adolescent Substance Abuse: From Diagnosis and Treatment to Risk Management and Medico Legal Concerns** Timothy E. Wilens, MD
4:15 - 5:15PM**	The Ethical and Safe On- and Off-Label Use of Psychotropics in Practice Thomas J. Spencer, MD; Timothy E. Wilens, MD; Janet Wozniak, MD Moderator**: Joseph Biederman, MD
5:15 - 6:30PM	Dinner (on your own)
6:30 - 7:30PM	Evening Seminars Participants may choose only one seminar presentation to attend. 1. Managing the Complex Patient with Autism Spectrum Disorders Gagan Joshi, MD 2. Managing the Complex Adolescent Patient Paul Hammerness, MD 3. Managing the Complex Adult with ADHD Craig Surman, MD

Saturday, March 10, 2012

7:30 - 8:00AM	Continental Breakfast
8:00 - 9:00AM	Juvenile Depression Karen Wagner, MD, PhD
9:00 - 9:45AM	Juvenile Mania (Part 1): Diagnosis and Correlates Janet Wozniak, MD
9:45 - 10:30AM	Juvenile Mania (Part 2): Treatment Janet Wozniak, MD
10:30 - 10:45AM	Coffee Break
10:45 - 11:45AM	Managing First Episode Psychosis Oliver Freudenreich, MD
11:45 - 1:00PM	Lunch (On your own)
1:00 - 2:00PM	Tourette’s Disorder & Tics Barbara Coffey, MD, MS
2:00 - 3:00PM	Autism Spectrum Disorders Gagan Joshi, MD
3:00 - 3:15PM	Coffee Break
3:15 - 4:15PM	Cognitive Behavioral Treatment in Pediatric Psychiatry Aude Henin, PhD
4:15 - 5:00PM	Neuropsychological Testing Alysa E. Doyle, PhD
5:00 - 6:30PM	Dinner (on your own)
6:30 - 7:30PM	Evening Seminars Seminars will be given at 6:30PM. Participants may choose only one seminar presentation to attend. 1. Educational Assessment and School Accommodations for Children with Psychiatric and Learning Disorders Alysa E. Doyle, PhD 2. How to Best Understand the Medical Literature Michael Monuteaux, ScD

Sunday, March 11, 2012

7:30 - 8:00AM	Continental Breakfast
8:00 - 9:00AM	Anxiety Disorders in Childhood and Adolescence Dina R. Hirshfeld-Becker, PhD, and Daniel A. Geller, MD
9:00 - 10:00AM	Juvenile Obsessive Compulsive Disorders Daniel A. Geller, MD
10:00 - 10:15AM	Coffee Break
10:15 - 11:00AM	Eating Disorders Esther J. Dechant, MD
11:00 - 11:45AM	Pediatric Consultation Liaison: Psychopharmacology in Clinical Practice Annah Abrams, MD
11:45 - 12:30PM	Multimodal Management of Pediatric Psychopharmacology Michael S. Jellinek
12:30 - 1:30PM	Lunch Break (on your own)
1:30 - 2:00PM**	Antidepressants and Suicide Risk and Prevention** Jefferson B. Prince, PhD
2:00 - 2:30PM**	Revisiting the Cardiovascular Side Effects and Medical Liability of Stimulants for ADHD** Paul Hammerness, MD
2:30 - 3:30PM**	Liability Prevention in Child and Adolescent Psychopharmacology** Ronald Schouten, MD, JD
3:30PM	Adjourn

** 4 credits meet the criteria of the Massachusetts Board of Registration in Medicine for risk management study.

Pricing

MDs/Doctoral Level Professionals:

$690.00

Discounted Price If Registered By Refund Policy
$635.00 Friday, February 17, 2012

Other Professionals and Trainees:

$540.00

Discounted Price If Registered By Refund Policy
$490.00 Friday, February 17, 2012

Faculty

Annah Abrams, MD

Child Psychiatrist, Pediatric Hematology Oncology Unit, MGH
Staff, Child Psychiatry Consultation Liaison Service, MGH
Assistant Professor of Psychiatry, Harvard Medical School
Pradeep G. Bhide, PhD

Associate Neuroscientist, MGH
Associate Professor of Neurology, Harvard Medical School
Joseph Biederman, MD

Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, MGH
Professor of Psychiatry, Harvard Medical School
Barbara Coffey, MD, MS

Director, Tics and Tourette's Clinical and Research Program, NYU Child Study Center
Associate Professor of Child and Adolescent Psychiatry and Psychiatry, NYU School of Medicine
Esther J. Dechant, MD

Medical Director, Klarman Eating Disorders Center, McLean Hospital
Instructor in Psychiatry, Harvard Medical School
Alysa E. Doyle, PhD

Director of Neuropsychology, Clinical and Research Program in Pediatric Psychopharmacology, MGH
Instructor in Psychiatry, Harvard Medical School
Oliver Freudenreich, MD

Director, First Episode and Early Psychosis Program, MGH
Director, Infectious Disease Consultation Service, MGH
Assistant Professor of Psychiatry, Harvard Medical School
Daniel A. Geller, MD

Director, Pediatric OCD Program, Clinical and Research Program in Pediatric Psychopharmacology, MGH
Associate Professor of Psychiatry, Harvard Medical School
Paul Hammerness, MD

Scientific Coordinator, Clinical and Research Program in Pediatric Psychopharmacology & Adult ADHD, MGH
Assistant Professor of Psychiatry, Harvard Medical School
Aude Henin, PhD

Co-Director, Child CBT Program, Department of Psychiatry, MGH
Director, CBT Program, Clinical and Research Program in Pediatric Psychopharmacology, MGH
Assistant Professor of Psychology in the Department of Psychiatry, Harvard Medical School
Dina R. Hirshfeld-Becker , PhD

Director of High-Risk Studies and Anxiety Research, Pediatric Psychopharmacology Program, MGH
Associate Professor of Psychiatry, Harvard Medical School
Michael S. Jellinek, MD

Chief, Child Psychiatry Service, MGH
President, Newton Wellesley Hospital
Professor of Psychiatry and of Pediatrics, Harvard Medical School
Gagan Joshi, MD

Clinical Investigator, Pediatric Psychopharmacology Clinical and Research Programs, MGH
Instructor in Psychiatry, Harvard Medical School
Michael Monuteaux, ScD

Assistant Director of Research, Pediatric Psychopharmacology Research Unit, MGH
Assistant Professor of Pediatrics, Harvard Medical School
Roy H. Perlis, MD

Medical Director, Bipolar Clinic and Research Program, MGH
Principal Investigator, Center for Human Genetic Research, MGH
Associate Professor of Psychiatry, Harvard Medical School
Jefferson B. Prince, PhD

Director of Child Psychiatry, North Shore Medical Center
Staff, Child Psychiatry and Pediatric Psychopharmacology Clinics, MGH
Instructor in Psychiatry, Harvard Medical School
Ronald Schouten, MD, JD

Director, Law & Psychiatry Service, MGH
Associate Professor of Psychiatry, Harvard Medical School
Thomas J. Spencer, MD

Assistant Director, Pediatric Psychopharmacology Unit, MGH
Assistant Chief, Department of Psychiatry, MGH
Associate Professor of Psychiatry, Harvard Medical School
Craig Surman, MD

Scientific Coordinator, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, MGH
Instructor in Psychiatry, Harvard Medical School
Karen Wagner, MD, PhD

Professor & Vice Chair, Dept. of Psychiatry & Behavioral Sciences, Univ. of Texas Medical Branch, Galveston
Director of the Division of Child and Adolescent Psychiatry, Univ. of Texas Medical Branch, Galveston
Timothy E. Wilens, MD

Director, Substance Abuse Services in Pediatric Psychopharmacology, MGH
Director, Center for Addiction Medicine, MGH
Associate Professor of Psychiatry, Harvard Medical School
Janet Wozniak, MD

Director, Pediatric Bipolar Disorder Clinical and Research Program, MGH
Assistant Professor of Psychiatry, Harvard Medical School